Compare Stocks → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:ARTHNYSE:ISR Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARTHArch Therapeutics$1.18+3.5%$1.91$0.39▼$18.00$5.60M3.523,850 shs618 shsISRIsoray$0.37$0.19▼$0.45$54.57M1.48290,697 shs145,000 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARTHArch Therapeutics+3.51%+1.72%-44.86%-71.15%-63.13%ISRIsoray0.00%0.00%0.00%0.00%0.00%Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARTHArch TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AISRIsorayN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARTHArch TherapeuticsN/AN/AN/AN/AISRIsorayN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARTHArch Therapeutics$80K69.94N/AN/A($2.43) per share-0.49ISRIsoray$10.80M0.00N/AN/A$0.43 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARTHArch Therapeutics-$6.98MN/A0.00∞N/A-6,809.45%N/A-386.74%5/20/2024 (Estimated)ISRIsoray-$7.27M-$0.07N/AN/AN/A-115.91%-17.12%-16.15%N/ALatest ARTH and ISR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/20/2024Q1 2024ARTHArch TherapeuticsN/A-$0.57-$0.57-$0.57N/A$0.05 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARTHArch TherapeuticsN/AN/AN/AN/AN/AISRIsorayN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARTHArch TherapeuticsN/A0.160.04ISRIsorayN/A14.3813.99OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARTHArch Therapeutics6.91%ISRIsoray11.32%Insider OwnershipCompanyInsider OwnershipARTHArch Therapeutics4.50%ISRIsoray2.42%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableARTHArch Therapeutics84.74 million4.53 millionNot OptionableISRIsorayN/A142.11 million138.67 millionNot OptionableARTH and ISR HeadlinesSourceHeadlineFrench ISR Label Revamp Reportmorningstar.com - November 22 at 1:20 PMUnexpected growth of Radiation Therapy Market in future with Top Companies Data, In-depth Analysis, Business I - openPRnews.google.com - May 13 at 8:02 PMMedical Brachytherapy Device Market: Is Thriving With Rising Latest ... - StreetBuzznews.google.com - May 13 at 3:01 PMRadiotherapy Devices Market Size To See Huge Growth By 2031 ... - Taiwan Newsnews.google.com - May 12 at 2:13 PMRadiotherapy Machines Market by Revenue, Growth, Demand and ... - Cottonwood Holladay Journalnews.google.com - May 11 at 7:59 AMRadiotherapy Market Opportunities, Development Status and ... - Cottonwood Holladay Journalnews.google.com - May 11 at 7:59 AMRadiation Oncology Market Opportunities, Development Status and ... - Cottonwood Holladay Journalnews.google.com - May 11 at 7:59 AMSuperficial Radiation Therapy System Market is expected to reach ... - Future Market Insightsnews.google.com - May 11 at 4:12 AMRadiation Therapy Market Size, Share, Industry, Forecast to 2030 - openPRnews.google.com - May 10 at 5:36 PMBrachytherapy Market Economic Aspect with Industry Capacity ... - Cottonwood Holladay Journalnews.google.com - May 10 at 5:36 PMBrachytherapy Market Stand Out As The Biggest Contributor To ... - Digital Journalnews.google.com - May 10 at 7:21 AMRadiotherapy Devices Market Analysis, Overview, Trends, Key ... - Cottonwood Holladay Journalnews.google.com - May 10 at 3:10 AMGlobal Intraoperative Radiation Therapy Market Size, Analysis ... - Cottonwood Holladay Journalnews.google.com - May 9 at 10:44 PMRadiation Therapy Market to Reach US$ 10.6 bn by 2031, Product ... - Digital Journalnews.google.com - May 9 at 4:20 PMPhilippines Radiotherapy Market Future Business Opportunities ... - Digital Journalnews.google.com - May 9 at 7:08 AMGlobal Radiotherapy Market 2023 Outlook By Product, Application ... - Cottonwood Holladay Journalnews.google.com - May 9 at 5:30 AMGlobal Teletherapy Machines Market Research Report 2023 by ... - The Northwestern Examinernews.google.com - May 8 at 3:01 PMGlobal Pituitary Cancer Market Key Leaders Analysis, Segmentation ... - The Northwestern Examinernews.google.com - May 8 at 3:01 PMGlobal Tumor Radiation Therapy Market 2022 to 2031 Analysis ... - Fylladeynews.google.com - May 7 at 1:37 PMVIVOS INC Management's Discussion and Analysis of Financial ... - Marketscreener.comnews.google.com - May 4 at 5:47 PMTumor Radiation Therapy to Witness Huge Growth by 2031 | Elekta ... - Fylladeynews.google.com - May 4 at 5:47 PMP2X7 Receptor Antagonists Market : Quantitative Market Analysis ... - Digital Journalnews.google.com - May 4 at 7:47 AMThree-Dimensional Conformal Radiation Therapy Market Data Acquisition Research Report Study, it's Trends, and - openPRnews.google.com - May 3 at 8:36 AMDosimetric Impact of Source Displacement in GammaTile Surgically ... - Cureusnews.google.com - May 3 at 2:25 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsArch TherapeuticsOTCMKTS:ARTHArch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.IsorayNYSE:ISRIsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
